Developer docs
API playgroundTry for free, no card

Search company profiles

CARPL.ai

Full company profile

uuid0000va3

Namestring
CARPL.ai
Legal namestring
Carpl.AI, Inc.
Websiteurl
carpl.ai
Company typeenum
Private
Founded yearint
2018
Descriptiontext

CARPL.ai is a private radiology AI platform company founded in 2018 and headquartered in San Francisco, California, with an operating entity (CARPL.AI Pvt Ltd) in New Delhi, India and a legal registration in Cupertino. The company operates an FDA 510(k) cleared enterprise imaging AI platform that aggregates third-party radiology AI applications and provides a single integration pipeline for healthcare providers to discover, validate, test, and deploy medical imaging AI solutions. Its core products include a Universal AI Viewer (infrastructure-agnostic, on-premise or cloud-deployable), an AI Marketplace positioned as the world's largest radiology AI marketplace with 300+ applications from 100+ vendors, and a proprietary Validation & Testing Module that produces single-click performance reports with AUC-ROC curves, confusion matrices, and drift detection. The platform supports both on-premise and cloud deployments, integrates with major PACS and RIS systems, and includes workflow features such as intelligent triaging, urgency flagging, and report auto-population.

The revenue model combines enterprise platform licensing (subscription-based, quote-driven) with potential marketplace commission from AI vendors commercializing through CARPL's deployed base. Go-to-market relies on direct enterprise sales to large healthcare systems, embedded distribution through PACS vendor partnerships (Fujifilm, Agfa, Intelerad, Ramsoft, Adva PACS, PaxeraHealth, Philips), and channel partners such as Medica Group and NTT DATA. Named customers span more than 15 enterprise logos across the United States (Mass General, University Hospitals Cleveland, RadNet/DeepHealth), Brazil (Fleury, Einstein Hospital Israelita, FIDI), Singapore (Synapxe, Tan Tock Seng, Changi General), Australia (I-MED, Qscan), India (AIIMS), and the UK/Ireland (Royal Marsden, Medica NHS Trusts). The company employs 11-50 people and has raised $6 million in seed funding led by Stellaris Venture Partners in February 2024, with a potential $5 million investment from the IFC reportedly in consideration in February 2026.

Short descriptiontext

CARPL.ai operates an FDA 510(k) cleared enterprise imaging AI platform that enables healthcare providers to discover, validate, test, and deploy 300+ third-party radiology AI applications through a single integration pipeline. It serves hospitals, health systems, teleradiology providers, and AI vendors across the US, Brazil, Singapore, Australia, India, and the UK/Ireland.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersCupertino, United States
HQ citystring
Cupertino
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
radiology AI platform, medical imaging AI, AI orchestration, radiology AI marketplace, imaging AI validation
Industry3 codes
PRIMARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHDAEANAA
End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHDAEANAF
AI Observability, Monitoring & Evaluation Platforms (Drift, Quality, Safety)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
NAICS code1 code
  • Medical and Diagnostic Laboratories62151
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Radiology AI Platform
Revenue model2 records
1Enterprise Platform Licensing
TypeSubscription Recurring
Description

Subscription-based licensing model for enterprise healthcare organizations to access the CARPL platform including AI marketplace, universal viewer, validation tools, and deployment capabilities. Provides single window access to discover, test, and deploy world-class medical imaging AI solutions.

carpl.ai
2AI Marketplace Commission
TypeMarketplace Commission
Description

CARPL serves as a marketplace for AI developers to commercialize their radiology AI solutions, potentially generating commission or transaction fees from AI vendors accessing the deployment base and user-base through single technical integration.

carpl.ai
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1Women in AI Community
Description

A global community dedicated to women in AI, promoting learning, creativity, and purpose-driven impact in healthcare technology.

carpl.ai
Core offering1 text field

CARPL.ai operates an FDA 510(k) cleared enterprise platform for the discovery, exploration, validation, and deployment of medical imaging AI. It combines a marketplace of 300+ third-party radiology AI applications from 100+ vendors with a universal AI viewer, pre-deployment validation tools, post-deployment monitoring, and infrastructure-agnostic deployment (on-premise or cloud) with PACS/RIS interoperability.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 30% acceleration in MSK x-ray interpretation at University Hospitals Cleveland
+5 more records
Product overview1 text field

CARPL.ai offers a unified radiology AI platform consisting of three interconnected core products: the AI Marketplace (offering 300+ applications from 100+ vendors), the Enterprise AI Platform (FDA 510(k) cleared, providing pre-deployment validation and post-deployment monitoring), and the Universal AI Viewer (providing a standardized interface across all AI outputs). The platform enables healthcare providers to discover, test, validate, and deploy AI solutions through a single integration point, supporting both cloud and on-premise deployments.

Product and service1 record
1Universal AI Viewer
Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-06-11
Description

Partnership to improve AI validation workflows for imaging customers through Enlitic's Ensight platform which structures and normalizes imaging data. Collaboration addresses data fragmentation in healthcare organizations, a key barrier to AI adoption in radiology, enabling faster identification and preparation of imaging studies for evaluation. Both companies aim to accelerate the path from AI exploration to real-world deployment in healthcare settings.

Strategic tierStrategicTypeImplementation/ SI/ Consulting PartnerAnnounced on2026-03-11
Description

NTT DATA partnered with The Royal Marsden NHS Foundation Trust and CARPL.ai to build AI-powered radiology service for brain tumour care. NTT DATA provides infrastructure and implementation services while CARPL provides the AI platform layer.

Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2026-03-11
Description

UK's leading cancer center built AI-powered radiology service with NTT DATA and CARPL.ai for brain tumour care. Represents flagship use case for combining sovereign AI compute with governed health data to achieve better patient outcomes.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-03-06
Description

CARPL partnered with Medica Group to deploy its radiology AI marketplace and enterprise platform for teleradiology services across NHS Trusts in the UK and Ireland. Platform provides access to more than 200 licensed and validated AI tools, with Radiobotics' RBfracture among the first deployed for high-volume fracture detection processing up to 2,500 examinations per day. Partnership marks significant shift in how AI is validated and embedded into live clinical workflows at a national level.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-11-17
Description

Vesta Teleradiology showcased AI-powered radiology workflow innovations at RSNA 2025 including new collaborations with Qure.ai, CARPL.ai, RadPair, and SimpliRad. Vesta integrated third-party AI technologies and internal platforms to improve radiology reporting, workflow, accuracy, and operational efficiency.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-07-19
Description

DeepHealth leverages strategic collaborations with TeraRecon and CARPL.ai to scale deployment. DeepHealth's Diagnostic Suite and SmartMammo solutions deployed in NHS England Lung Cancer Screening Program where 76% of detected cancers were caught at earlier stages. CARPL chosen as AI platform partner due to technological and clinical prowess. DeepHealth's partnership with CARPL creates unique environment to dynamically run combination of models and monitor performance.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnership with Philips for radiology AI integration. Integration of AI results into PACS increases workflow efficiency and potentially reduces turnaround times for thoracic care. Philips positions CARPL as potentially ideal platform for Philips customers.

Strategic tierStrategicTypeTechnology or Integration
Description

PACS integration partnership enabling CARPL's AI capabilities to be accessed through Fujifilm's Synapse PACS system, providing seamless workflow for radiologists.

Strategic tierStrategicTypeTechnology or Integration
Description

PACS integration partnership enabling interoperability between CARPL's AI platform and Agfa's radiology imaging systems.

10Intelerad
Strategic tierStrategicTypeTechnology or Integration
Description

PACS integration partnership enabling CARPL's AI platform capabilities to be accessed through Intelerad's imaging workflow solutions.

carpl.ai
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Blackford Analysis provides a radiology AI orchestration and integration platform that lets hospitals deploy multiple third-party AI algorithms through a single workflow. It is the closest direct peer to CARPL's marketplace and orchestration proposition in radiology imaging.

TypeEmerging player
Description

Qure.ai develops radiology AI algorithms (head CT, chest X-ray, TB) and distributes through both its own channels and partnerships including CARPL's marketplace. Adjacent vendor that increasingly competes for hospital AI deployment budgets.

TypeDirect peer
Description

Medimsight (formerly EnvoyAI) operates a marketplace and integration layer for radiology AI algorithms. Directly comparable to CARPL's AI marketplace and orchestration engine for hospitals.

TypeDirect peer
Description

Enlitic provides an AI platform that structures and normalizes medical imaging data for downstream algorithm deployment, and is now a CARPL partner. It overlaps with CARPL's validation and data-preparation workflow and competes in adjacent parts of the imaging AI orchestration stack.

TypeEmerging player
Description

Aidoc is a leading radiology AI vendor whose algorithms are available on CARPL's marketplace but which also offers its own aiOS orchestration platform. Represents both a marketplace vendor and a direct competing platform layer.

TypeBroad incumbent
Description

Siemens Healthineers offers AI-Rad Companion and broader digital health orchestration capabilities across its imaging equipment portfolio. Competes with CARPL as an integrated vendor offering both modalities and AI deployment.

TypeEmerging player
Description

DeepHealth, the AI subsidiary of RadNet, both partners with CARPL and develops its own diagnostic AI suite (e.g., SmartMammo) deployed through similar PACS-integrated workflows. Part ally, part competitor in the radiology AI orchestration space.

8TeraRecon
TypeDirect peer
Description

TeraRecon (now part of ConcertAI) offers advanced visualization and AI orchestration for radiology, including a multi-vendor AI algorithm marketplace integrated into its viewer. Competes directly with CARPL's universal viewer and orchestration capabilities.

TypeBroad incumbent
Description

GE Healthcare's Edison AI platform aggregates imaging AI applications and serves as an orchestration layer within GE imaging equipment and PACS. As a broad incumbent, it competes with CARPL's marketplace approach via embedded distribution across GE's installed base.

TypeDirect peer
Description

Microsoft's Nuance Precision Imaging Network is an AI marketplace that distributes radiology AI algorithms to healthcare providers via the Nuance PowerScribe/PowerConnect workflow. Directly competes with CARPL's marketplace distribution model in the US enterprise radiology segment.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat7 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers17 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration7 records

Each record includes

Title, Type, Description, Source

AI capability10 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CARPL.ai

Radiology AI Platformcarpl.ai

CARPL.ai operates an FDA 510(k) cleared enterprise imaging AI platform that enables healthcare providers to discover, validate, test, and deploy 300+ third-party radiology AI applications through a single integration pipeline. It serves hospitals, health systems, teleradiology providers, and AI vendors across the US, Brazil, Singapore, Australia, India, and the UK/Ireland.

What CARPL.ai does

CARPL.ai is a private radiology AI platform company founded in 2018 and headquartered in San Francisco, California, with an operating entity (CARPL.AI Pvt Ltd) in New Delhi, India and a legal registration in Cupertino. The company operates an FDA 510(k) cleared enterprise imaging AI platform that aggregates third-party radiology AI applications and provides a single integration pipeline for healthcare providers to discover, validate, test, and deploy medical imaging AI solutions. Its core products include a Universal AI Viewer (infrastructure-agnostic, on-premise or cloud-deployable), an AI Marketplace positioned as the world's largest radiology AI marketplace with 300+ applications from 100+ vendors, and a proprietary Validation & Testing Module that produces single-click performance reports with AUC-ROC curves, confusion matrices, and drift detection. The platform supports both on-premise and cloud deployments, integrates with major PACS and RIS systems, and includes workflow features such as intelligent triaging, urgency flagging, and report auto-population.

The revenue model combines enterprise platform licensing (subscription-based, quote-driven) with potential marketplace commission from AI vendors commercializing through CARPL's deployed base. Go-to-market relies on direct enterprise sales to large healthcare systems, embedded distribution through PACS vendor partnerships (Fujifilm, Agfa, Intelerad, Ramsoft, Adva PACS, PaxeraHealth, Philips), and channel partners such as Medica Group and NTT DATA. Named customers span more than 15 enterprise logos across the United States (Mass General, University Hospitals Cleveland, RadNet/DeepHealth), Brazil (Fleury, Einstein Hospital Israelita, FIDI), Singapore (Synapxe, Tan Tock Seng, Changi General), Australia (I-MED, Qscan), India (AIIMS), and the UK/Ireland (Royal Marsden, Medica NHS Trusts). The company employs 11-50 people and has raised $6 million in seed funding led by Stellaris Venture Partners in February 2024, with a potential $5 million investment from the IFC reportedly in consideration in February 2026.

CARPL.ai firmographics

Firmographics
Name
CARPL.ai
Legal name
Carpl.AI, Inc.
Website
https://carpl.ai
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
51–100 employees
Short description
CARPL.ai operates an FDA 510(k) cleared enterprise imaging AI platform that enables healthcare providers to discover, validate, test, and deploy 300+ third-party radiology AI applications through a single integration pipeline. It serves hospitals, health systems, teleradiology providers, and AI vendors across the US, Brazil, Singapore, Australia, India, and the UK/Ireland.
Ownership category
akta.pro rank

CARPL.ai industry classification

Industry
Product category
Radiology AI Platform
NAICS
Medical and Diagnostic Laboratories (62151)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACALAG
AI Orchestration & Imaging Analytics Platforms (Model Management/Triage)
Healthcare & Life Sciences/Digital Health & Health IT/Medical Imaging Informatics (PACS/RIS/VNA) & Radiology IT
SECONDARYHDAEANAA
End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise
SECONDARYHDAEANAF
AI Observability, Monitoring & Evaluation Platforms (Drift, Quality, Safety)
Hardware, Technology & Telecom/Enterprise Platforms & Databases/Artificial Intelligence Platforms for Enterprise

Keywords

  • Radiology AI platform
  • Medical imaging AI
  • AI orchestration
  • Radiology AI marketplace
  • Imaging AI validation

Where CARPL.ai is headquartered

Location

Headquarters

HQ city
Cupertino
HQ country
United States
HQ region
North America

Offices3 records

Markets served

CARPL.ai business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Enterprise Platform Licensing: Subscription-based licensing model for enterprise healthcare organizations to access the CARPL platform including AI marketplace, universal viewer, validation tools, and deployment capabilities. Provides single window access to discover, test, and deploy world-class medical imaging AI solutions.
  2. AI Marketplace Commission: CARPL serves as a marketplace for AI developers to commercialize their radiology AI solutions, potentially generating commission or transaction fees from AI vendors accessing the deployment base and user-base through single technical integration.

Distribution channels4 records

Marketing channels9 records

CARPL.ai product offering

Product offering

Core offering

CARPL.ai operates an FDA 510(k) cleared enterprise platform for the discovery, exploration, validation, and deployment of medical imaging AI. It combines a marketplace of 300+ third-party radiology AI applications from 100+ vendors with a universal AI viewer, pre-deployment validation tools, post-deployment monitoring, and infrastructure-agnostic deployment (on-premise or cloud) with PACS/RIS interoperability.

Product overview

CARPL.ai offers a unified radiology AI platform consisting of three interconnected core products: the AI Marketplace (offering 300+ applications from 100+ vendors), the Enterprise AI Platform (FDA 510(k) cleared, providing pre-deployment validation and post-deployment monitoring), and the Universal AI Viewer (providing a standardized interface across all AI outputs). The platform enables healthcare providers to discover, test, validate, and deploy AI solutions through a single integration point, supporting both cloud and on-premise deployments.

Differentiator

Problem solved

Functional benefit

Brands

  • Women in AI Community: A global community dedicated to women in AI, promoting learning, creativity, and purpose-driven impact in healthcare technology.

Products and services

  • Universal AI Viewer

Quantifiable outcome

  • 30% acceleration in MSK x-ray interpretation at University Hospitals Cleveland
  • +5 more outcomes

Companies that use CARPL.ai

Customer profile

Named customers17 records

Segments5 records

Ideal customer profiles4 records

CARPL.ai technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration7 records

AI capability10 records

Feature6 records

CARPL.ai partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and strategic.

  • EnliticcoreTechnology or Integration · 11 June 2026Partnership to improve AI validation workflows for imaging customers through Enlitic's Ensight platform which structures and normalizes imaging data. Collaboration addresses data fragmentation in healthcare organizations, a key barrier to AI adoption in radiology, enabling faster identification and preparation of imaging studies for evaluation. Both companies aim to accelerate the path from AI exploration to real-world deployment in healthcare settings.
  • NTT DATAstrategicImplementation/ SI/ Consulting Partner · 11 March 2026NTT DATA partnered with The Royal Marsden NHS Foundation Trust and CARPL.ai to build AI-powered radiology service for brain tumour care. NTT DATA provides infrastructure and implementation services while CARPL provides the AI platform layer.
  • Royal Marsden NHS Foundation TruststrategicStrategic or Co-development Partner · 11 March 2026UK's leading cancer center built AI-powered radiology service with NTT DATA and CARPL.ai for brain tumour care. Represents flagship use case for combining sovereign AI compute with governed health data to achieve better patient outcomes.
  • Medica GroupcoreChannel Partner/ Reseller/ Distributor · 6 March 2026CARPL partnered with Medica Group to deploy its radiology AI marketplace and enterprise platform for teleradiology services across NHS Trusts in the UK and Ireland. Platform provides access to more than 200 licensed and validated AI tools, with Radiobotics' RBfracture among the first deployed for high-volume fracture detection processing up to 2,500 examinations per day. Partnership marks significant shift in how AI is validated and embedded into live clinical workflows at a national level.
  • Vesta TeleradiologycoreTechnology or Integration · 17 November 2025Vesta Teleradiology showcased AI-powered radiology workflow innovations at RSNA 2025 including new collaborations with Qure.ai, CARPL.ai, RadPair, and SimpliRad. Vesta integrated third-party AI technologies and internal platforms to improve radiology reporting, workflow, accuracy, and operational efficiency.
  • DeepHealth (RadNet subsidiary)coreStrategic or Co-development Partner · 19 July 2025DeepHealth leverages strategic collaborations with TeraRecon and CARPL.ai to scale deployment. DeepHealth's Diagnostic Suite and SmartMammo solutions deployed in NHS England Lung Cancer Screening Program where 76% of detected cancers were caught at earlier stages. CARPL chosen as AI platform partner due to technological and clinical prowess. DeepHealth's partnership with CARPL creates unique environment to dynamically run combination of models and monitor performance.
  • PhilipscoreStrategic or Co-development PartnerStrategic partnership with Philips for radiology AI integration. Integration of AI results into PACS increases workflow efficiency and potentially reduces turnaround times for thoracic care. Philips positions CARPL as potentially ideal platform for Philips customers.
  • FujifilmstrategicTechnology or IntegrationPACS integration partnership enabling CARPL's AI capabilities to be accessed through Fujifilm's Synapse PACS system, providing seamless workflow for radiologists.
  • Agfa HealthcarestrategicTechnology or IntegrationPACS integration partnership enabling interoperability between CARPL's AI platform and Agfa's radiology imaging systems.
  • InteleradstrategicTechnology or IntegrationPACS integration partnership enabling CARPL's AI platform capabilities to be accessed through Intelerad's imaging workflow solutions.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

CARPL.ai competitors and assessment

Company assessment

Direct peers

  • Blackford Analysis: Blackford Analysis provides a radiology AI orchestration and integration platform that lets hospitals deploy multiple third-party AI algorithms through a single workflow. It is the closest direct peer to CARPL's marketplace and orchestration proposition in radiology imaging.
  • EnvoyAI (now Medimsight): Medimsight (formerly EnvoyAI) operates a marketplace and integration layer for radiology AI algorithms. Directly comparable to CARPL's AI marketplace and orchestration engine for hospitals.
  • Enlitic: Enlitic provides an AI platform that structures and normalizes medical imaging data for downstream algorithm deployment, and is now a CARPL partner. It overlaps with CARPL's validation and data-preparation workflow and competes in adjacent parts of the imaging AI orchestration stack.
  • TeraRecon: TeraRecon (now part of ConcertAI) offers advanced visualization and AI orchestration for radiology, including a multi-vendor AI algorithm marketplace integrated into its viewer. Competes directly with CARPL's universal viewer and orchestration capabilities.
  • Nuance Precision Imaging Network (Microsoft): Microsoft's Nuance Precision Imaging Network is an AI marketplace that distributes radiology AI algorithms to healthcare providers via the Nuance PowerScribe/PowerConnect workflow. Directly competes with CARPL's marketplace distribution model in the US enterprise radiology segment.

Emerging players

  • Qure.ai: Qure.ai develops radiology AI algorithms (head CT, chest X-ray, TB) and distributes through both its own channels and partnerships including CARPL's marketplace. Adjacent vendor that increasingly competes for hospital AI deployment budgets.
  • Aidoc: Aidoc is a leading radiology AI vendor whose algorithms are available on CARPL's marketplace but which also offers its own aiOS orchestration platform. Represents both a marketplace vendor and a direct competing platform layer.
  • DeepHealth (RadNet subsidiary): DeepHealth, the AI subsidiary of RadNet, both partners with CARPL and develops its own diagnostic AI suite (e.g., SmartMammo) deployed through similar PACS-integrated workflows. Part ally, part competitor in the radiology AI orchestration space.

Broad incumbents

  • Siemens Healthineers (AI-Rad Companion): Siemens Healthineers offers AI-Rad Companion and broader digital health orchestration capabilities across its imaging equipment portfolio. Competes with CARPL as an integrated vendor offering both modalities and AI deployment.
  • GE Healthcare (Edison AI Platform): GE Healthcare's Edison AI platform aggregates imaging AI applications and serves as an orchestration layer within GE imaging equipment and PACS. As a broad incumbent, it competes with CARPL's marketplace approach via embedded distribution across GE's installed base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

CARPL.ai social profiles

Digital presence

CARPL.ai compliance and trust

Trust signal

Compliance1 record

CARPL.ai financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CARPL.ai leadership team

Management profile

Number of profiles

Profiles6 records

CARPL.ai funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CARPL.ai M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CARPL.ai

What does CARPL.ai do?

CARPL.ai operates an FDA 510(k) cleared enterprise platform for the discovery, exploration, validation, and deployment of medical imaging AI. It combines a marketplace of 300+ third-party radiology AI applications from 100+ vendors with a universal AI viewer, pre-deployment validation tools, post-deployment monitoring, and infrastructure-agnostic deployment (on-premise or cloud) with PACS/RIS interoperability.

Is CARPL.ai a public or private company?

CARPL.ai is a private company. It is classified as venture growth investor backed and is currently operating.

When was CARPL.ai founded?

CARPL.ai was founded in 2018. It employs 51 to 100 people.

Where is CARPL.ai based?

CARPL.ai is headquartered in Cupertino, United States, in the North America region.

How does CARPL.ai make money?

Two revenue lines are on record. Enterprise Platform Licensing is the primary driver. The others are AI Marketplace Commission.

Who are CARPL.ai's main competitors?

Direct peers on record are Blackford Analysis, EnvoyAI (now Medimsight), Enlitic, TeraRecon and Nuance Precision Imaging Network (Microsoft). Emerging players are Qure.ai, Aidoc and DeepHealth (RadNet subsidiary). Broad incumbents are Siemens Healthineers (AI-Rad Companion) and GE Healthcare (Edison AI Platform).

Does CARPL.ai have an API?

Yes. CARPL.ai provides an API for technical integration. The Terms of Use reference API usage, stating users 'use any method to extract data from these services, including web scraping, web harvesting, or web data extraction methods, other than as permitted through the API.' This indicates a formal API exists for authorized data access and integration.

What industry is CARPL.ai in?

CARPL.ai's product category is Radiology AI Platform. Its primary akta.pro industry code is HLACALAG, AI Orchestration & Imaging Analytics Platforms (Model Management/Triage), with a secondary code of HDAEANAA, End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management). Its NAICS code is 62151 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Imaging Technology NewsHOPPR, CARPL.ai Announce CollaborationCARPL.ai and HOPPR announced a collaboration enabling healthcare providers to securely develop, fine-tune, and deploy custom radiology AI applications using HOPPR's foundation models. The partnership removes barriers like massive computational resources and proprietary datasets, allowing teams to fine-tune models with local imaging data. The companies plan to expand capabilities across imaging modalities and use CARPL's post-market surveillance tools.AETOSWireWorld-Leading Cancer Center, The Royal Marsden NHS Foundation Trust, Using AI to Push Boundaries of Cancer Research With NTT DATA and CARPL.aiThe Royal Marsden NHS Foundation Trust partnered with NTT DATA and CARPL.ai to build an AI-powered radiology analysis service for cancer research, funded by a three-year NIHR grant. The service will evaluate AI algorithms for sarcoma, lung, breast, brain, and prostate cancers, aiming to improve diagnosis and treatment. NTT DATA will continue supporting the next phase of research.PR NewswireHOPPR and CARPL.ai partner to give customers access to foundation models for building and fine-tuning radiology AICARPL.ai and HOPPR announced a partnership to give healthcare providers access to HOPPR's foundation models for building and fine-tuning radiology AI applications. The collaboration removes barriers like massive computational resources and proprietary datasets, enabling secure fine-tuning with local imaging data. The companies plan to expand capabilities across imaging modalities and use CARPL's post-market surveillance tools.EIN PresswireCARPL.ai and GenServe.AI Partner to Connect Radiology AI to Patient CareCARPL.ai and GenServe.AI announced a partnership to connect radiology AI with autonomous patient care workflows. The collaboration aims to close referral gaps, reduce missed appointments, and improve exam preparation, with GenServe's AI applications available through CARPL's marketplace. The companies will demonstrate the combined solution at Becker's, HLTH, and RSNA.PR NewswireMedical Image Analysis Software Market worth $6.42 billion by 2031 - Exclusive Report by MarketsandMarkets™The medical image analysis software market is projected to grow from USD 4.35 billion in 2026 to USD 6.42 billion by 2031, an 8.1% CAGR. North America held the largest regional share at 38.4% in 2025, and the integrated software segment accounted for 64.5% of the market. AI-enabled technology is expected to see the fastest growth at 8.6% CAGR.BW DisruptCARPL.ai Raises $10 Mn Series A Led By IFC To Scale Healthcare AICARPL.ai, a radiology AI marketplace and enterprise platform, has raised USD 10 million in a Series A funding round led by the International Finance Corporation (IFC), with participation from Stellaris Venture Partners. The capital will fund product development, partner ecosystem expansion, and commercial growth across North America, Latin America, Europe, Asia-Pacific and emerging markets, while building engineering capabilities in India. The company currently hosts over 300 AI applications from more than 100 partners and serves healthcare organisations including four of the world's top five private radiology groups.Indian Startup NewsHealthtech startup CARPL.ai raises $10 million from International Finance CorporationHealthtech startup CARPL.ai has raised $10 million in a Series A funding round led by the International Finance Corporation, with participation from Stellaris Venture Partners. The funding will support product development and global commercial expansion across North America, Latin America, Europe, Asia-Pacific, and emerging markets. The company operates a vendor-neutral platform for AI applications in radiology, serving major private radiology groups and government health systems in Brazil, India, Singapore, Spain, and the UAE.IncubeesHealthtech startup CARPL.ai raises $10 M Series A funding from IFC – IncubeesThe International Finance Corporation led a $10 million Series A funding round for healthtech startup CARPL.ai, with participation from existing investor Stellaris Venture Partners and other unidentified investors. The funding will be used to strengthen CARPL.ai's technology stack, accelerate product development, and expand its global sales and delivery operations. CARPL.ai operates an AI-powered marketplace offering over 300 medical imaging AI applications from more than 100 suppliers, currently serving 30 hospitals and medical facilities across North America, Europe, Middle East, India, Southeast Asia, Australia, and Latin America.Radiology BusinessRadiology artificial intelligence marketplace CARPL.ai raises $10MCARPL.ai has raised $10 million in a Series A funding round led by International Finance Corp. (IFC), the private sector arm of the World Bank Group, with participation from India-based Stellaris Venture Partners. Founded in 2021 and dual-headquartered in Delhi and San Francisco, CARPL positions itself as the world's largest radiology AI marketplace with over 300 applications across 100-plus AI partners, and the funds will support new product development, partner network expansion, and commercial growth in North America and beyond. The company, whose platform is currently used by four of the world's five top radiology groups and deployed by governments in Brazil, India, Singapore, and Spain, plans to expand beyond medical imaging into pathology, genomics, and general medicine.Digital Health NewsCARPL.ai Secures $10 Mn Series A Led by IFC to Expand Global Healthcare AI PlatformCARPL.ai, a California-based healthtech startup, has secured $10 million in a Series A funding round led by the International Finance Corporation (IFC), with participation from Stellaris Venture Partners and other investors. The funding will support enhancement of its vendor-neutral radiology AI platform and marketplace, expansion of international operations, and wider adoption of medical imaging AI across healthcare organizations. The startup, founded by Dr. Vidur Mahajan, plans to extend its platform beyond radiology into pathology, genomics, and general medicine as part of its long-term vision to become an integration and governance layer for clinical AI.